BSW Wealth Partners Lowers Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)

BSW Wealth Partners cut its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK) by 15.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,626 shares of the company’s stock after selling 3,464 shares during the period. BSW Wealth Partners’ holdings in Takeda Pharmaceutical were worth $247,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in TAK. Versant Capital Management Inc purchased a new position in shares of Takeda Pharmaceutical in the 4th quarter worth about $26,000. Wilmington Savings Fund Society FSB bought a new position in Takeda Pharmaceutical during the third quarter valued at approximately $40,000. BNP Paribas Financial Markets raised its stake in shares of Takeda Pharmaceutical by 416.0% during the third quarter. BNP Paribas Financial Markets now owns 3,220 shares of the company’s stock worth $46,000 after acquiring an additional 2,596 shares in the last quarter. Smithfield Trust Co lifted its holdings in shares of Takeda Pharmaceutical by 76.9% in the 3rd quarter. Smithfield Trust Co now owns 3,428 shares of the company’s stock worth $49,000 after acquiring an additional 1,490 shares during the last quarter. Finally, Erste Asset Management GmbH bought a new position in shares of Takeda Pharmaceutical during the 3rd quarter valued at $52,000. Institutional investors own 9.17% of the company’s stock.

Takeda Pharmaceutical Price Performance

Shares of NYSE:TAK opened at $13.35 on Thursday. The company’s fifty day moving average is $13.30 and its 200 day moving average is $13.89. The company has a quick ratio of 0.77, a current ratio of 1.28 and a debt-to-equity ratio of 0.64. Takeda Pharmaceutical Company Limited has a 52 week low of $12.57 and a 52 week high of $15.08. The stock has a market cap of $42.46 billion, a PE ratio of 23.01, a PEG ratio of 0.24 and a beta of 0.51.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.